Report post

What is paradigm biopharmaceuticals?

Paradigm Biopharmaceuticals | 2,396 followers on LinkedIn. Paradigm’s (ASX:PAR) immediate commercial focus is the development of pentosan polysulfate sodium (PPS) for the treatment of osteoarthritis (OA). This is a global unmet need and we have advanced to phase 3 trials in the space.

Did paradigm biopharmaceuticals raise $50 million?

Paradigm Biopharmaceuticals was in the market on Thursday, seeking to raise $50 million. Copyright © 2024. Company information displayed on The Australian Financial Review is sourced from Morningstar and ASX and is subject to their terms and conditions as set out in our Terms of Use.

Why should you invest in paradigm Biopharma?

to life Combining cutting edge science and unparalleled experience to transform underutilised molecules, Paradigm Biopharma brings a dynamic approach to some of the world’s most significant unmet needs; offering a new avenue of hope to patients and a new opportunity to investors.

The World's Leading Crypto Trading Platform

Get my welcome gifts